Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the long-term safety and tolerability of treatment
with balsalazide disodium tablets in subjects who are in remission from ulcerative colitis or
who have mildly to moderately active UC.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.